Trial Profile
A Open-label Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Perampanel (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Epilepsy; Migraine; Multiple sclerosis; Neuropathic pain; Parkinson's disease; Pregnancy
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 14 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2010 New trial record